Purpose-built for physicians GLP-1s may lower risk for all-cause mortality, hospitalization in type 1 diabetes Key takeaways: Adults with type 1 diabetes who used an incretin-based drug had lower risk for all-cause mortality than nonusers
Research published in the British Medical Journal in January 2026 suggested that people quickly put most of the weight lost back on when they stop taking the drugs, as their normal food cravings return
Stahn V, Nagel I, Fischer-Huchzermeyer S, Oyen F, Schneppenheim R, Gesk S, Bohring A, Chikobava L, Young P, Gess B, Werner M, Senner V, Harder A (2016) Molecular analysis of hybrid neurofibroma/schwannoma identifies common monosomy 22 and -T-catenin/CTNNA3 as a novel candidate tumor suppressor
Si no hay, purga otra vez, hasta que salga un poco de Ozempic